Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer.
Ye L, Lin C, Wang X, Li Q, Li Y, Wang M, Zhao Z, Wu X, Shi D, Xiao Y, Ren L, Jian Y, Yang M, Ou R, Deng G, Ouyang Y, Chen X, Li J, Song L.
Ye L, et al. Among authors: li y, li j, li q.
EMBO Mol Med. 2019 Dec;11(12):e10638. doi: 10.15252/emmm.201910638. Epub 2019 Oct 28.
EMBO Mol Med. 2019.
PMID: 31657150
Free PMC article.